Matt Meyerson

Charles A. Dana Chair in Human Cancer Genetics, Dana-Farber Cancer Institute

Professor of Genetics and Medicine, Harvard Medical School

Director, Center for Cancer Genomics, Dana-Farber Cancer Institute

Dana Farber Cancer Institute

617-632-4377

Meyerson Lab

Publications

Preclinical response of uveal melanomas to the velcrin compound, BAY 2666605.

Authors: Authors: Kotýnková K, Andersen S, Denney D, Karsli Uzunbas G, Burri M, Wu X, Kaplan B, Haq R, Meyerson M, Greulich H.
Mol Cancer Ther 2026-06-02
View full abstract on Pubmed

A Roadmap to Transform Lung Cancer Outcomes: Priorities in Biology, Therapeutic Innovation, Early Detection, Prevention, and Interception.

Authors: Authors: Winslow MM, Ahmed MA, Berg CD, Black JRM, Downward J, Govindan R, Herbst RS, Heymach JV, Jaffee EM, Kraut N, Merad M, Meyerson M, Pandya T, Politi K, Rao AV, Rudin CM, Soria JC, Tang YJ, Wong KK, Yap TA, Swanton C.
Cancer Discov 2026-06-01
View full abstract on Pubmed

ErbB family receptor dimerization dynamics and dysregulation via long-term single-molecule imaging.

Authors: Authors: Ma K, Ma X, Shida JF, Niu Z, Lin YK, Mandal S, Dobbins A, Golomb L, Eck MJ, Greulich H, Meyerson M, Peng CS.
Cell 2026-05-28
View full abstract on Pubmed

Aneuploidy sensitizes cells to SREBP-pathway inhibition in squamous cell carcinoma.

Authors: Authors: Zhakula-Kostadinova N, Jain S, Amini-Farsani Z, Zhang J, Nakamura M, Byron L, Castellano Perez JJ, Paolucci C, Munoth R, Zandkarimi F, Takemon Y, Marra M, Henick B, Saqi A, Reya T, Meyerson M, Taylor AM.
bioRxiv 2026-05-08
View full abstract on Pubmed

Biodiversity and biogeography of the multi-kingdom cancer microbiome.

Authors: Authors: Dohlman AB, Mjelle R, Wood HM, Jiang K, Shumate A, Lee I, Piccinno G, Serna G, Yakubu AR, Nuciforo P, Quirke P, Huttenhower C, Segata N, Meyerson M.
Cell 2026-05-05
View full abstract on Pubmed

Rapid loss of viability in acute myeloid leukemia cells upon telomerase inactivation.

Authors: Authors: Aquilanti E, Kageler L, Bozinov V, Meyerson M.
Blood Adv 2026-03-10
View full abstract on Pubmed

Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung Cancer.

Authors: Authors: Siegel F, Siegel S, Kotýnková K, Karsli Uzunbas G, Korr D, Tomono H, Andersen S, Denney D, Berger M, Schulze VK, Lewis TA, Kaplan B, Golfier S, Mortier J, Hillig RC, Boemer U, Petersen K, Eis K, Williams S, Rüttinger D, Cherniack AD, Loong HH, Goto K, Grassi P, Meyerson M, Greulich H.
Cancer Discov 2026-01-12
View full abstract on Pubmed

Detecting foldback artifacts in long-reads.

Authors: Authors: Heinz JM, Meyerson M, Li H.
BMC Genomics 2026-01-07
View full abstract on Pubmed

Detecting Foldback Artifacts in Long-reads.

Authors: Authors: Heinz JM, Meyerson M, Li H.
bioRxiv 2025-11-19
View full abstract on Pubmed

MYC amplification and MYC protein expression are poor prognostic markers in pediatric and young adult osteosarcoma.

Authors: Authors: Nagy MR, Puopolo O, Alston E, Challa S, Ceca E, Li Y, Cherniack AD, Lazo de la Vega L, Meyerson M, Church AJ, Janeway K.
Cancer 2025-11-15
View full abstract on Pubmed